Estimates Revisions Enlivex

Stocks

Market Closed - Nasdaq 21:00:00 28/08/2026 BST			5-day change	1st Jan Change
1.350 ^USD	-8.47%		-8.16%	-87.20%

07-28	Enlivex Ltd. announced that it expects to receive $400 million in funding	CI
07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI